Opened 360 days ago

Closes 31 August 2025

Study Aim Description

The Neuropharmacogenetics project is recruiting young adults with a lived experience of depression and/or anxiety. The aim is to gain a better understanding of the strategies to improve the awareness and understanding of personalised medicine techniques in young people. You will be asked to share your understanding of personalised medicine, the ways in which you gather health information, and your perception of the benefits of improving health awareness in young people.

What You Will Do

    • Attend one focus group/interview session of approx. 1-1.5 hours
    • Receive compensation for your time

Study Eligibility

      • 18-24 years of age
      • Have a lived experience of depression and/or anxiety
      • Fluent in written and spoken English
      • Able to give informed consent to attend one of the focus group sessions
      • Have been prescribed medication by your GP or psychiatrists for treatment of depression and/or anxiety

Trial Coordinator

Georgia Landery 23090511@student.uwa.edu.au
Bradley Roberts brad.roberts@perron.uwa.edu.au

Study Approval: UWA HREC Study Number: 2024/ET000004

Interested? Enquire today

Principal Investigator: Professor P. Anthony Akkari

View more trials